Literature DB >> 6381523

Comparison of serum mannan, arabinitol, and mannose in experimental disseminated candidiasis.

L de Repentigny, R J Kuykendall, F W Chandler, J R Broderson, E Reiss.   

Abstract

Concentrations of arabinitol, mannose, and mannan in serum have independently been reported to be elevated in patients with invasive candidiasis. These three marker substances were compared in a rabbit model. Twelve rabbits, immunosuppressed with cortisone, were infected intravenously with Candida albicans 3181A. Six uninfected control animals also received cortisone, and four rabbits were neither infected nor immunosuppressed. Blood samples, drawn from 2 days before to 14 days after infection, were assayed for serum mannan by sandwich enzyme immunoassay, antibodies to mannan by indirect enzyme immunoassay, arabinitol and mannose by gas-liquid chromatography, and serum creatinine. Serum mannan, negative before infection, peaked in all infected animals 4 days after infection (mean, 18 ng/ml) and decreased thereafter. Significant increases (2 standard deviations greater than mean in normals) in arabinitol, the arabinitol/creatinine ratio, and mannose were found in 12, 8, and 12 of the infected rabbits, respectively, but also in all 6 uninfected animals receiving cortisone. Only serum mannan was specific in this immunosuppressed rabbit model.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6381523      PMCID: PMC271189          DOI: 10.1128/jcm.19.6.804-812.1984

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  29 in total

1.  Candidiasis: detection by gas-liquid chromatography of D-arabinitol, a fungal metabolite, in human serum.

Authors:  T E Kiehn; E M Bernard; J W Gold; D Armstrong
Journal:  Science       Date:  1979-11-02       Impact factor: 47.728

2.  Partially purified antibodies used in a solid-phase radioimmunoassay for detecting candidal antigenemia.

Authors:  A H Poor; J E Cutler
Journal:  J Clin Microbiol       Date:  1979-03       Impact factor: 5.948

Review 3.  Severe candidal infections: clinical perspective, immune defense mechanisms, and current concepts of therapy.

Authors:  J E Edwards; R I Lehrer; E R Stiehm; T J Fischer; L S Young
Journal:  Ann Intern Med       Date:  1978-07       Impact factor: 25.391

4.  Detection by counterimmunoelectrophoresis of anti-Candida precipitins in sera from cancer patients.

Authors:  R L Hopfer; D Gröschel
Journal:  Am J Clin Pathol       Date:  1979-08       Impact factor: 2.493

5.  The arabinitol appearance rate in laboratory animals and humans: estimation from the arabinitol/creatine ratio and relevance to the diagnosis of candidiasis.

Authors:  B Wong; E M Bernard; J W Gold; D Fong; D Armstrong
Journal:  J Infect Dis       Date:  1982-09       Impact factor: 5.226

6.  Serum levels of arabinitol in the detection of invasive candidiasis in animals and humans.

Authors:  R H Eng; H Chmel; M Buse
Journal:  J Infect Dis       Date:  1981-05       Impact factor: 5.226

7.  Increased arabinitol levels in experimental candidiasis in rats: arabinitol appearance rates, arabinitol/creatinine ratios, and severity of infection.

Authors:  B Wong; E M Bernard; J W Gold; D Fong; A Silber; D Armstrong
Journal:  J Infect Dis       Date:  1982-09       Impact factor: 5.226

8.  Enhanced detection with an enzyme-linked immunosorbent assay of candida mannan in antibody-containing serum after heat extraction.

Authors:  M A Lew; G R Siber; D M Donahue; F Maiorca
Journal:  J Infect Dis       Date:  1982-01       Impact factor: 5.226

9.  Mannose in body fluids as an indicator of invasive candidiasis.

Authors:  T P Monson; K P Wilkinson
Journal:  J Clin Microbiol       Date:  1981-11       Impact factor: 5.948

10.  Comparison by ELISA of serum anti-Candida albicans mannan IgG levels of a normal population and in diseased patients.

Authors:  P F Lehmann; E Reiss
Journal:  Mycopathologia       Date:  1980-03-17       Impact factor: 2.574

View more
  23 in total

1.  Monoclonal antibodies against Candida tropicalis mannan: antigen detection by enzyme immunoassay and immunofluorescence.

Authors:  E Reiss; L de Repentigny; R J Kuykendall; A W Carter; R Galindo; P Auger; S L Bragg; L Kaufman
Journal:  J Clin Microbiol       Date:  1986-11       Impact factor: 5.948

2.  Altered hepatic clearance and killing of Candida albicans in the isolated perfused mouse liver model.

Authors:  R T Sawyer; M N Horst; R E Garner; J Hudson; P R Jenkins; A L Richardson
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

3.  Effects of gastrointestinal candidiasis, antibiotics, dietary arabinitol, and cortisone acetate on levels of the Candida metabolite D-arabinitol in rat serum and urine.

Authors:  B Wong; K L Brauer; J R Clemens; S Beggs
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

Review 4.  Laboratory diagnosis of invasive candidiasis.

Authors:  J M Jones
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

5.  Studies on detection of Candida antigen in the sera of mice inoculated orally with Candida albicans.

Authors:  H Suzuki; H Taguchi; K Nishimura; M Miyaji; A Nakamura; H Nakajima
Journal:  Mycopathologia       Date:  1988-10       Impact factor: 2.574

6.  Comparison of enzyme immunoassay and gas-liquid chromatography for the rapid diagnosis of invasive candidiasis in cancer patients.

Authors:  L de Repentigny; L D Marr; J W Keller; A W Carter; R J Kuykendall; L Kaufman; E Reiss
Journal:  J Clin Microbiol       Date:  1985-06       Impact factor: 5.948

7.  Diagnosis of systemic candidiasis: development of co-counterimmunoelectrophoresis.

Authors:  D Poulain; J M Pinon
Journal:  Eur J Clin Microbiol       Date:  1986-08       Impact factor: 3.267

8.  Evaluation of enzyme immunoassay for Candida cytoplasmic antigens in neutropenic cancer patients.

Authors:  M Morhart; R Rennie; B Ziola; E Bow; T J Louie
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

9.  Estimations of serum arabinitol for diagnosing invasive candidosis.

Authors:  A G Deacon
Journal:  J Clin Pathol       Date:  1986-08       Impact factor: 3.411

10.  Competitive binding inhibition enzyme-linked immunosorbent assay that uses the secreted aspartyl proteinase of Candida albicans as an antigenic marker for diagnosis of disseminated candidiasis.

Authors:  Christine J Morrison; Steven F Hurst; Errol Reiss
Journal:  Clin Diagn Lab Immunol       Date:  2003-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.